• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与免疫调节生物制剂相关的感染性并发症。

Infectious complications associated with immunomodulating biologic agents.

机构信息

Division of Infectious Diseases, Brigham and Women's Hospital, 75 Francis Street, PBB-A4, Boston, MA 02115, USA.

出版信息

Infect Dis Clin North Am. 2010 Jun;24(2):285-306. doi: 10.1016/j.idc.2010.01.006.

DOI:10.1016/j.idc.2010.01.006
PMID:20466271
Abstract

The armamentarium of biologic therapies targeting specific elements of the immune system is rapidly expanding. This review describes the spectrum of infectious complications associated to date with each of the immunomodulating biologic therapies approved by the US Food and Drug Administration.

摘要

针对免疫系统特定元素的生物治疗药物的武器库正在迅速扩大。本综述描述了迄今为止与美国食品和药物管理局批准的每种免疫调节生物治疗药物相关的感染并发症谱。

相似文献

1
Infectious complications associated with immunomodulating biologic agents.与免疫调节生物制剂相关的感染性并发症。
Infect Dis Clin North Am. 2010 Jun;24(2):285-306. doi: 10.1016/j.idc.2010.01.006.
2
Infectious complications associated with immunomodulating biologic agents.与免疫调节生物制剂相关的感染性并发症。
Hematol Oncol Clin North Am. 2011 Feb;25(1):117-38. doi: 10.1016/j.hoc.2010.11.009.
3
Biologic therapy and risk of infection.
Skin Therapy Lett. 2012 Apr;17(4):1-4.
4
[Infectious complications as a consequence of treatment with nucleoside analogs and monoclonal antibodies].
Dtsch Med Wochenschr. 2006 Oct 27;131(43):2414-9. doi: 10.1055/s-2006-955025.
5
Potential complications associated with the use of biologic agents for psoriasis.使用生物制剂治疗银屑病相关的潜在并发症。
Dermatol Clin. 2007 Apr;25(2):207-13, vii. doi: 10.1016/j.det.2007.01.010.
6
Infectious complications of biologic agents.生物制剂的感染性并发症。
Rheum Dis Clin North Am. 2009 Feb;35(1):183-99. doi: 10.1016/j.rdc.2009.03.009.
7
Pulmonary infectious diseases in patients with primary immunodeficiency and those treated with biologic immunomodulating agents.原发性免疫缺陷病患者和接受生物免疫调节剂治疗患者的肺部感染性疾病。
Curr Opin Pulm Med. 2011 May;17(3):172-9. doi: 10.1097/MCP.0b013e3283455c0b.
8
Rituximab: a B-cell depletion therapy for dermatologic disease.利妥昔单抗:一种用于皮肤病的B细胞清除疗法。
Skin Therapy Lett. 2007 Jul-Aug;12(6):6-9.
9
Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura.一名接受利妥昔单抗治疗特发性血小板减少性紫癜的患者出现严重感染并发症。
Ann Hematol. 2007 Mar;86(3):225-6. doi: 10.1007/s00277-006-0206-1. Epub 2006 Oct 10.
10
The drugs from within.来自体内的药物。
Curr Opin Investig Drugs. 2009 Apr;10(4):303-4.

引用本文的文献

1
Adalimumab-associated Philadelphia chromosome positive acute lymphoblastic leukaemia in a patient with Crohn's disease.阿达木单抗相关费城染色体阳性急性淋巴细胞白血病在克罗恩病患者中。
BMJ Case Rep. 2023 Oct 24;16(10):e255604. doi: 10.1136/bcr-2023-255604.
2
Impact of a Dedicated Pretransplant Infectious Disease Consultation on Respiratory Tract Infections in Kidney Allograft Recipients: A Retrospective Study of 516 Recipients.专门的移植前传染病会诊对肾移植受者呼吸道感染的影响:一项对516名受者的回顾性研究
Pathogens. 2023 Jan 3;12(1):74. doi: 10.3390/pathogens12010074.
3
Case Report: Histoplasma Hepatitis Presenting as Common Bile Duct Obstruction.
病例报告:表现为胆总管梗阻的组织胞浆菌性肝炎
Am J Trop Med Hyg. 2022 Apr 11;106(6):1627-8. doi: 10.4269/ajtmh.21-1049.
4
Hypersensitivity reactions to monoclonal antibodies: Classification and treatment approach (Review).单克隆抗体的超敏反应:分类与治疗方法(综述)
Exp Ther Med. 2021 Sep;22(3):949. doi: 10.3892/etm.2021.10381. Epub 2021 Jul 3.
5
[Travelling with children and adolescents with rheumatic diseases].[与患有风湿性疾病的儿童和青少年一同旅行]
Z Rheumatol. 2021 Sep;80(7):620-628. doi: 10.1007/s00393-021-01002-6. Epub 2021 Apr 27.
6
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series.英夫利昔单抗治疗皮质类固醇难治性免疫检查点抑制剂相关性心肌炎:病例系列
Cardiooncology. 2021 Mar 30;7(1):13. doi: 10.1186/s40959-021-00095-x.
7
A new side of sarcoidosis: medication and hospitalization use in a privately insured patient population.结节病的新面貌:私人保险患者群体中的药物治疗与住院情况
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(2):124-129. doi: 10.36141/svdld.v36i2.7206. Epub 2019 May 1.
8
Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States.分析美国市场扫描数据中的免疫抑制状况和急性呼吸道疾病住院情况。
Emerg Infect Dis. 2020 Aug;26(8):1720-1730. doi: 10.3201/eid2608.191493. Epub 2020 Apr 29.
9
Early Lyme Borreliosis in Patients Treated with Tumour Necrosis Factor-Alfa Inhibitors.接受肿瘤坏死因子-α抑制剂治疗患者的早期莱姆病螺旋体病
J Clin Med. 2019 Nov 2;8(11):1857. doi: 10.3390/jcm8111857.
10
HLA-B27 spondyloarthritis and spotted fever rickettsiosis: case-based review.HLA-B27 相关性脊柱关节炎与斑点热立克次体病:基于病例的综述。
Rheumatol Int. 2019 Sep;39(9):1643-1650. doi: 10.1007/s00296-019-04330-8. Epub 2019 May 27.